PVP K-30 (Polyvinylpyrrolidone K-30) Market latest Statistics on Market Size, Growth, Production, Sales Volume, Sales Price, Market Share and Import vs Export 

PVP K-30 (Polyvinylpyrrolidone K-30) Market Summary Highlights

The PVP K-30 (Polyvinylpyrrolidone K-30) Market is demonstrating steady expansion driven by its multifunctional role across pharmaceuticals, cosmetics, food processing, and industrial applications. As a water-soluble polymer with strong binding, film-forming, and stabilizing properties, PVP K-30 continues to gain traction in high-growth sectors. Demand is being shaped by pharmaceutical formulation advancements, rising personal care consumption, and increasing use in specialty coatings and adhesives.

From an analytical standpoint, the PVP K-30 (Polyvinylpyrrolidone K-30) Market is benefiting from structural demand shifts rather than cyclical factors. Pharmaceutical-grade PVP K-30 dominates consumption, accounting for over 45% of total volume in 2025, while cosmetics and industrial segments are growing at faster rates. Asia-Pacific remains the largest production and consumption hub, with China and India collectively contributing more than 50% of global supply.

The PVP K-30 (Polyvinylpyrrolidone K-30) Market Size is projected to grow at a CAGR of 6.8%–7.5% between 2025 and 2030, supported by increasing investments in drug delivery technologies and premium personal care products. Supply chain optimization and raw material cost fluctuations continue to influence pricing trends, but overall margin stability is improving due to process efficiencies.

PVP K-30 (Polyvinylpyrrolidone K-30) Market Statistical Snapshot

• The PVP K-30 (Polyvinylpyrrolidone K-30) Market is projected to reach approximately USD 1.25 billion by 2026
• CAGR estimated at 7.2% from 2025 to 2030
• Pharmaceutical applications account for ~45% market share in 2025
• Cosmetics and personal care segment growing at 8.5% CAGR through 2030
• Asia-Pacific holds over 52% of global consumption
• China contributes ~35% of global production capacity
• Binder applications in tablets represent nearly 60% of pharmaceutical demand
• Industrial usage (adhesives, coatings) accounts for ~20% of total volume
• Average price fluctuation range remains within 4%–6% annually due to raw material volatility
• High-purity grades are expected to grow 1.4x faster than standard grades by 2030

PVP K-30 (Polyvinylpyrrolidone K-30) Market Trend: Pharmaceutical Industry Expansion Driving Core Demand

The PVP K-30 (Polyvinylpyrrolidone K-30) Market is primarily driven by its critical role in pharmaceutical formulations, particularly as a binder in tablet manufacturing and a solubilizing agent in drug delivery systems. Pharmaceutical production volumes are increasing at a sustained pace, with global drug manufacturing output projected to grow by 6.5% annually through 2026.

For instance, tablet-based drug formulations continue to dominate oral dosage forms, accounting for over 70% of pharmaceutical production globally. Within this segment, PVP K-30 usage as a binder is nearly universal due to its excellent compressibility and compatibility with active pharmaceutical ingredients (APIs). This directly translates to a proportional increase in demand within the PVP K-30 (Polyvinylpyrrolidone K-30) Market.

In addition, the rise of poorly soluble drugs—estimated to constitute over 40% of new drug pipelines—is accelerating the adoption of PVP K-30 as a solubilizer. Its role in enhancing bioavailability makes it indispensable in modern drug delivery systems. As a result, pharmaceutical-grade PVP K-30 demand is expected to grow at over 8% CAGR, outpacing overall market growth.

PVP K-30 (Polyvinylpyrrolidone K-30) Market Driver: Rapid Growth in Cosmetics and Personal Care Applications

The cosmetics and personal care industry is emerging as a significant growth driver for the PVP K-30 (Polyvinylpyrrolidone K-30) Market, particularly in hair care, skincare, and color cosmetics. PVP K-30 functions as a film-forming agent and stabilizer, widely used in hair sprays, gels, and lotions.

Global personal care product consumption is increasing at a rate of 7% annually, with premium and functional formulations gaining higher market share. For example, hair styling products alone are projected to exceed USD 25 billion in global revenue by 2026, with PVP K-30 being a key ingredient in over 60% of formulations.

Furthermore, demand for long-lasting and high-performance cosmetics is increasing, especially in urban markets. This trend directly supports the PVP K-30 (Polyvinylpyrrolidone K-30) Market, as manufacturers increasingly incorporate advanced polymers to enhance product durability and user experience.

Asia-Pacific leads this segment due to rising disposable incomes and expanding middle-class populations. The region is expected to witness over 9% CAGR in cosmetic-grade PVP K-30 consumption through 2030.

PVP K-30 (Polyvinylpyrrolidone K-30) Market Trend: Industrial Applications Expanding Beyond Traditional Uses

Industrial applications are contributing to the diversification of the PVP K-30 (Polyvinylpyrrolidone K-30) Market, particularly in adhesives, coatings, textiles, and inks. PVP K-30’s binding and dispersing properties make it suitable for specialty formulations requiring high stability and uniformity.

For instance, the global adhesives market is projected to grow at 5.5% annually, with increasing demand from packaging, construction, and automotive industries. PVP K-30 is used in water-based adhesives due to its solubility and film-forming characteristics, supporting environmentally friendly formulations.

Similarly, in coatings and inks, PVP K-30 acts as a dispersant, improving pigment stability and enhancing finish quality. The shift toward eco-friendly and water-based systems is further accelerating its adoption.

As industrial sectors transition toward sustainable materials, the PVP K-30 (Polyvinylpyrrolidone K-30) Market is expected to benefit from increased integration into green chemistry applications.

PVP K-30 (Polyvinylpyrrolidone K-30) Market Driver: Rising Demand for High-Purity and Specialty Grades

A notable trend within the PVP K-30 (Polyvinylpyrrolidone K-30) Market is the increasing demand for high-purity and pharmaceutical-grade variants. Regulatory requirements for excipients are becoming more stringent, particularly in developed markets such as North America and Europe.

High-purity PVP K-30 grades are essential for applications requiring low impurity levels, such as injectable drugs and advanced drug delivery systems. These grades are priced 20%–30% higher than standard variants, contributing to overall market value growth.

For example, the demand for injectable formulations is increasing at over 9% annually, driven by biologics and specialty drugs. This directly impacts the PVP K-30 (Polyvinylpyrrolidone K-30) Market Size, as higher-value products gain a larger share of total revenue.

Manufacturers are investing in advanced purification technologies to meet these requirements, thereby improving margins and product differentiation.

PVP K-30 (Polyvinylpyrrolidone K-30) Market Trend: Asia-Pacific Dominance and Capacity Expansion

The PVP K-30 (Polyvinylpyrrolidone K-30) Market is geographically concentrated in Asia-Pacific, with China and India serving as major production hubs. These countries offer cost advantages, robust chemical manufacturing infrastructure, and strong domestic demand.

China alone accounts for approximately 35%–38% of global PVP K-30 production capacity in 2025. India is emerging as a key exporter, supported by government incentives and expanding pharmaceutical manufacturing capabilities.

Capacity expansions are ongoing, with several manufacturers increasing output by 10%–15% annually to meet rising demand. For instance, new production lines are being established to cater specifically to pharmaceutical-grade PVP K-30.

This regional dominance also influences global pricing dynamics. Lower production costs in Asia-Pacific enable competitive pricing, although fluctuations in raw material availability—particularly vinylpyrrolidone—can impact margins.

The PVP K-30 (Polyvinylpyrrolidone K-30) Market Size is therefore closely linked to production trends in this region, making Asia-Pacific a critical focal point for both supply and demand analysis.

PVP K-30 (Polyvinylpyrrolidone K-30) Market Driver: Innovation in Drug Delivery and Functional Polymers

Innovation in pharmaceutical technology is another major driver shaping the PVP K-30 (Polyvinylpyrrolidone K-30) Market. The shift toward complex drug formulations, including controlled-release and targeted delivery systems, is increasing the demand for functional excipients.

PVP K-30 is widely used in solid dispersions to improve drug solubility and stability. The global market for advanced drug delivery systems is projected to grow at over 8% annually, creating significant opportunities.

For example, solid dispersion technologies are being increasingly adopted for oncology and CNS drugs, where bioavailability is critical. This trend directly supports higher consumption within the PVP K-30 (Polyvinylpyrrolidone K-30) Market.

Additionally, research into polymer-based drug carriers is expanding, with PVP derivatives being explored for nanotechnology applications. These developments indicate long-term growth potential beyond traditional uses.

PVP K-30 (Polyvinylpyrrolidone K-30) Market Regional Demand Dynamics

The PVP K-30 (Polyvinylpyrrolidone K-30) Market demonstrates strong regional demand concentration, with Asia-Pacific, North America, and Europe collectively accounting for over 85% of global consumption in 2025. Asia-Pacific leads with more than 52% share, driven by pharmaceutical manufacturing expansion and rising personal care consumption.

For instance, China and India together consume over 48% of total global volumes, supported by domestic API production growth exceeding 7% annually. In India, tablet production capacity has increased by nearly 9% year-on-year, directly influencing excipient demand such as PVP K-30. This trend positions the PVP K-30 (Polyvinylpyrrolidone K-30) Market as highly responsive to pharmaceutical output cycles.

North America accounts for approximately 18% of the PVP K-30 (Polyvinylpyrrolidone K-30) Market, characterized by high-value pharmaceutical-grade demand. For example, over 65% of excipient consumption in the U.S. is concentrated in regulated drug manufacturing, where purity standards are stringent. This results in higher per-unit consumption value compared to Asia-Pacific.

Europe contributes around 15% share, with Germany, France, and Italy leading consumption. The region’s focus on specialty chemicals and advanced drug delivery systems is driving demand growth at 5.5%–6% annually. Meanwhile, Latin America and Middle East & Africa collectively account for less than 15% but are emerging markets with growth rates exceeding 7%, particularly in Brazil and GCC countries.

PVP K-30 (Polyvinylpyrrolidone K-30) Market Demand by Application Regions

Within the PVP K-30 (Polyvinylpyrrolidone K-30) Market, application-specific demand varies significantly by region. Pharmaceutical consumption dominates in developed markets, while cosmetics and industrial applications are gaining traction in emerging economies.

For instance:

• In North America, pharmaceutical applications account for over 55% of regional demand
• In Asia-Pacific, pharmaceuticals hold ~42%, while cosmetics contribute nearly 30%
• In Europe, industrial usage (coatings and adhesives) represents close to 25% share

This regional variation reflects differences in industrial maturity and consumer behavior. For example, rising urbanization in Southeast Asia is pushing personal care product consumption growth above 9%, which directly accelerates demand within the PVP K-30 (Polyvinylpyrrolidone K-30) Market.

Additionally, contract manufacturing organizations (CMOs) in Asia are expanding at over 8% annually, further strengthening regional demand for pharmaceutical excipients.

PVP K-30 (Polyvinylpyrrolidone K-30) Market Production Landscape and Capacity Trends

The PVP K-30 (Polyvinylpyrrolidone K-30) Market is highly dependent on regional production clusters, with Asia-Pacific dominating global supply. China alone accounts for approximately 35%–38% of total output, followed by India at around 12%–15%.

Production capacity expansion is accelerating, with global output increasing at nearly 6.5% annually to meet rising demand. For instance, several manufacturers have announced capacity additions ranging from 8% to 12% annually, particularly for pharmaceutical-grade PVP K-30.

Backward integration into raw materials such as N-vinylpyrrolidone is becoming a strategic priority, reducing supply chain risks and stabilizing margins. This trend strengthens the overall resilience of the PVP K-30 (Polyvinylpyrrolidone K-30) Market, particularly during periods of feedstock volatility.

Moreover, production technologies are evolving, with continuous polymerization processes improving yield efficiency by 10%–15%. This enhances cost competitiveness, especially for large-scale producers in Asia.

PVP K-30 (Polyvinylpyrrolidone K-30) Market Production Trend and Statistics

The PVP K-30 (Polyvinylpyrrolidone K-30) Market is witnessing consistent expansion in manufacturing output, with global PVP K-30 (Polyvinylpyrrolidone K-30) production estimated to exceed 420 kilotons in 2025. Annual PVP K-30 (Polyvinylpyrrolidone K-30) production growth is tracking at approximately 6%–7%, closely aligned with pharmaceutical and personal care sector expansion.

Asia-Pacific dominates PVP K-30 (Polyvinylpyrrolidone K-30) production, contributing more than 55% of total global volumes. For example, China’s PVP K-30 (Polyvinylpyrrolidone K-30) production alone surpasses 150 kilotons annually, supported by large-scale integrated facilities. India’s PVP K-30 (Polyvinylpyrrolidone K-30) production is also increasing steadily, with output rising by nearly 8% year-on-year due to growing export demand.

In contrast, Europe and North America maintain smaller but high-value PVP K-30 (Polyvinylpyrrolidone K-30) production capacities, focusing on specialty and pharmaceutical-grade variants. These regions prioritize quality over volume, resulting in higher pricing benchmarks.

Capacity utilization rates globally are estimated at 78%–82%, indicating room for expansion while maintaining supply-demand balance. This production trend supports sustained growth within the PVP K-30 (Polyvinylpyrrolidone K-30) Market without significant oversupply risks.

PVP K-30 (Polyvinylpyrrolidone K-30) Market Segmentation Overview

The PVP K-30 (Polyvinylpyrrolidone K-30) Market is segmented across application, grade, and end-use industry, reflecting its diverse functional properties. Each segment exhibits distinct growth trajectories based on demand drivers and regulatory requirements.

Segmentation Highlights – PVP K-30 (Polyvinylpyrrolidone K-30) Market

By Application:

• Pharmaceuticals: ~45% share, growing at 8% CAGR
• Cosmetics & Personal Care: ~28% share, growing at 8.5% CAGR
• Industrial (Adhesives, Coatings, Textiles): ~20% share
• Food & Beverages: ~7% share, niche but stable growth

By Grade:

• Pharmaceutical Grade: Dominates with over 50% share
• Industrial Grade: ~30% share, driven by adhesives and coatings
• Cosmetic Grade: ~20% share, fastest growth segment

By End-Use Industry:

• Healthcare & Pharma: Largest contributor
• Personal Care & Cosmetics: High-growth segment
• Chemical & Industrial Manufacturing: Stable demand
• Food Processing: Limited but consistent usage

This segmentation structure highlights the diversified demand base of the PVP K-30 (Polyvinylpyrrolidone K-30) Market, reducing dependency on any single industry.

PVP K-30 (Polyvinylpyrrolidone K-30) Market Price Dynamics

The PVP K-30 (Polyvinylpyrrolidone K-30) Price is influenced by raw material costs, production efficiency, and regional supply-demand balance. The primary feedstock, N-vinylpyrrolidone, accounts for nearly 60% of total production cost, making price fluctuations highly sensitive to petrochemical trends.

In 2025, the average PVP K-30 (Polyvinylpyrrolidone K-30) Price ranges between USD 4,200 and USD 5,500 per metric ton, depending on grade and purity. Pharmaceutical-grade products command a premium of 25%–35% over industrial-grade variants.

For instance, high-purity PVP K-30 used in injectable formulations is priced significantly higher due to stringent quality requirements and additional processing steps. This pricing differential contributes to value growth within the PVP K-30 (Polyvinylpyrrolidone K-30) Market, even when volume growth is moderate.

PVP K-30 (Polyvinylpyrrolidone K-30) Market Price Trend Analysis

The PVP K-30 (Polyvinylpyrrolidone K-30) Price Trend indicates moderate volatility, with annual fluctuations typically ranging between 4% and 6%. This stability is supported by balanced supply-demand dynamics and gradual capacity expansions.

Between 2025 and 2026, the PVP K-30 (Polyvinylpyrrolidone K-30) Price Trend is expected to remain upward-biased, with incremental increases of 3%–4% annually. This is driven by rising demand for high-purity grades and increasing energy and compliance costs.

For example, environmental regulations in China have increased production costs by approximately 5%–7%, influencing global PVP K-30 (Polyvinylpyrrolidone K-30) Price benchmarks. Similarly, logistics and transportation costs continue to impact regional pricing disparities.

In Asia-Pacific, the PVP K-30 (Polyvinylpyrrolidone K-30) Price Trend remains relatively competitive due to lower manufacturing costs. In contrast, North America and Europe exhibit higher price levels, reflecting premium product positioning.

PVP K-30 (Polyvinylpyrrolidone K-30) Market Price Outlook and Margin Analysis

Looking ahead, the PVP K-30 (Polyvinylpyrrolidone K-30) Market is expected to experience gradual price stabilization, supported by improved supply chain integration and technological advancements in production.

The PVP K-30 (Polyvinylpyrrolidone K-30) Price Trend will increasingly be influenced by product differentiation rather than raw material volatility alone. For instance, specialty grades with enhanced functionality are expected to grow 1.5x faster than standard grades, allowing manufacturers to maintain higher margins.

Margin expansion is also supported by process optimization, with production cost reductions of 8%–10% achievable through continuous manufacturing technologies. This creates a favorable environment for sustained profitability within the PVP K-30 (Polyvinylpyrrolidone K-30) Market.

Overall, the interplay between regional production advantages, evolving application demand, and pricing strategies continues to define the competitive landscape of the PVP K-30 (Polyvinylpyrrolidone K-30) Market, ensuring steady growth and value creation through 2030.

PVP K-30 (Polyvinylpyrrolidone K-30) Market Competitive Landscape and Manufacturer Positioning

The PVP K-30 (Polyvinylpyrrolidone K-30) Market is characterized by a semi-consolidated structure where a limited number of multinational chemical and specialty polymer companies dominate high-value segments, while regional manufacturers compete aggressively in volume-driven categories. In 2025, the top five players account for approximately 60%–65% of total revenue, with a stronger concentration in pharmaceutical-grade products.

The competitive differentiation in the PVP K-30 (Polyvinylpyrrolidone K-30) Market is not volume alone but consistency, regulatory compliance, and purity levels. For instance, pharmaceutical excipient suppliers with US FDA and EU GMP certifications command premium contracts, while industrial-grade suppliers compete primarily on pricing. This dual-layer competitive structure ensures both stability and dynamic shifts in market share.

PVP K-30 (Polyvinylpyrrolidone K-30) Market Leading Manufacturers and Product Lines

The PVP K-30 (Polyvinylpyrrolidone K-30) Market includes several globally recognized manufacturers with specialized product portfolios designed for pharmaceuticals, cosmetics, and industrial applications.

BASF SE remains a dominant player through its Kollidon® product line, which is widely used in tablet binding, solubilization, and controlled-release systems. Kollidon® 30, in particular, is extensively integrated into pharmaceutical formulations due to its consistent molecular weight and excellent safety profile. BASF’s strength lies in its global distribution network and strong integration with pharmaceutical R&D.

Ashland Global Holdings holds the leading share in the PVP K-30 (Polyvinylpyrrolidone K-30) Market, primarily driven by its Plasdone™ series. These products are widely adopted in oral solid dosage formulations, where binding efficiency and dissolution control are critical. Ashland’s excipient portfolio is closely aligned with regulatory frameworks, allowing it to secure long-term supply agreements with major pharmaceutical manufacturers.

Croda International has strengthened its presence through specialty polymer innovation, particularly after integrating ISP technologies. Its PVP offerings are increasingly used in advanced personal care formulations, such as long-lasting hair styling products and high-performance skincare systems.

Nippon Shokubai and Nippon Fine Chemical focus on high-purity and specialty grades, particularly for regulated markets in Japan, Europe, and North America. Their competitive advantage lies in precision manufacturing and stringent quality control, making them preferred suppliers for niche pharmaceutical applications.

Boai NKY Pharmaceuticals and other Chinese manufacturers are expanding rapidly in the PVP K-30 (Polyvinylpyrrolidone K-30) Market, focusing on cost-efficient large-scale production. Their product lines cater to both pharmaceutical and industrial segments, with increasing penetration into export markets due to competitive pricing.

Additionally, companies such as Lamberti and Merck KGaA focus on high-value niche applications, including advanced drug delivery systems and research-grade polymers, further diversifying the competitive landscape.

PVP K-30 (Polyvinylpyrrolidone K-30) Market Share by Manufacturers

The PVP K-30 (Polyvinylpyrrolidone K-30) Market share by manufacturers reflects a tiered distribution where leadership is defined by product quality and regulatory compliance rather than sheer production volume.

Ashland leads with an estimated share of 35%–38% in 2025, supported by its strong pharmaceutical excipient portfolio and global client base. Its dominance is particularly evident in North America and Europe, where regulatory barriers limit entry for smaller players.

BASF holds approximately 18%–22% share in the PVP K-30 (Polyvinylpyrrolidone K-30) Market, leveraging its Kollidon brand and extensive integration across pharmaceutical and personal care industries. Its diversified application base provides resilience against sector-specific fluctuations.

Chinese manufacturers, led by Boai NKY, collectively account for 10%–15% of the global market. Their share is increasing steadily, driven by cost advantages and aggressive capacity expansion. For instance, their export volumes have grown by over 9% annually, enabling them to capture incremental global demand.

Nippon Shokubai and Croda each contribute around 5%–8% share, focusing on specialized and high-purity segments. Their growth is driven by innovation rather than volume, particularly in advanced pharmaceutical and cosmetic formulations.

The remaining 15%–20% of the PVP K-30 (Polyvinylpyrrolidone K-30) Market is fragmented among regional players, including Indian and European mid-sized manufacturers. These companies primarily serve local markets but are gradually expanding into exports.

PVP K-30 (Polyvinylpyrrolidone K-30) Market Strategic Positioning and Competitive Trends

The PVP K-30 (Polyvinylpyrrolidone K-30) Market is witnessing a clear strategic divide between innovation-driven and cost-driven players. Multinational companies are focusing on high-margin segments such as pharmaceutical-grade and specialty polymers, while regional manufacturers emphasize economies of scale.

For instance, pharmaceutical-grade PVP K-30 contributes over 50% of total market revenue despite accounting for a smaller share of volume. This indicates a strong value concentration in high-purity segments. Companies investing in regulatory approvals and advanced manufacturing technologies are capturing disproportionate value.

At the same time, industrial and cosmetic-grade PVP K-30 segments are becoming increasingly competitive, with price-sensitive buyers favoring suppliers offering cost advantages. This is particularly evident in Asia-Pacific, where local manufacturers are achieving production cost reductions of up to 20%.

Strategic collaborations are also shaping the PVP K-30 (Polyvinylpyrrolidone K-30) Market, with manufacturers entering partnerships with pharmaceutical companies to co-develop formulations. This approach enhances customer retention and creates barriers for new entrants.

PVP K-30 (Polyvinylpyrrolidone K-30) Market Recent Developments and Industry Timeline

Recent developments in the PVP K-30 (Polyvinylpyrrolidone K-30) Market highlight a strong focus on capacity expansion, technological innovation, and geographic diversification.

In early 2024, leading Asian manufacturers initiated capacity expansion projects, increasing production capabilities by 8%–10% annually to address rising global demand. These expansions are primarily focused on pharmaceutical-grade variants, reflecting shifting demand patterns.

By late 2024, major multinational players enhanced their production efficiency through process optimization technologies, reducing manufacturing costs by approximately 6%–8%. This has improved margin stability despite raw material price fluctuations.

During 2025, increased investments in R&D led to the development of advanced PVP-based excipients for controlled-release and solubility enhancement applications. These innovations are expected to drive higher adoption in complex drug formulations.

In 2026, the PVP K-30 (Polyvinylpyrrolidone K-30) Market is witnessing accelerated consolidation trends, with mid-sized manufacturers exploring mergers and strategic alliances to strengthen their global presence. At the same time, regulatory compliance requirements are becoming stricter, pushing smaller players to upgrade their production standards or exit high-value segments..